Activated monocytes in peritumoral stroma of hepatocellular carcinoma foster immune privilege and disease progression through PD-L1. - Wikidata - wikimedia - TriplyDB

Activated monocytes in peritumoral stroma of hepatocellular carcinoma foster immune privilege and disease progression through PD-L1.

Activated monocytes in peritumoral stroma of hepatocellular carcinoma foster immune privilege and disease progression through PD-L1.

http://www.wikidata.org/entity/Q37273173

about

Immunobiology of hepatocarcinogenesis: Ways to go or almost there?Cancer-associated fibroblasts in hepatocellular carcinoma Immune Checkpoint Modulators: An Emerging Antiglioma Armamentarium Neutrophils in Cancer: Two Sides of the Same Coin Regulation of epithelial-mesenchymal transition by tumor-associated macrophages in cancer Clinicopathologic Significance and Prognostic Value of B7 Homolog 1 in Gastric Cancer: A Systematic Review and Meta-Analysis Exploiting the Immunomodulatory Properties of Chemotherapeutic Drugs to Improve the Success of Cancer Immunotherapy Immunology of hepatocellular carcinoma Immunosuppressive Mechanisms of Malignant Gliomas: Parallels at Non-CNS Sites Current advances in immunotherapy for pancreatic cancer Novel aspects of the liver microenvironment in hepatocellular carcinoma pathogenesis and development Therapeutic cancer vaccines: past, present, and future Immune cell promotion of metastasis Mechanisms driving macrophage diversity and specialization in distinct tumor microenvironments and parallelisms with other tissues Cancer-associated fibroblasts in digestive tumors The blockade of immune checkpoints in cancer immunotherapy The PD1:PD-L1/2 Pathway from Discovery to Clinical Implementation Targeting immune checkpoints in malignant glioma The Kynurenine Pathway Is a Double-Edged Sword in Immune-Privileged Sites and in Cancer: Implications for Immunotherapy PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations Targeting tumor-associated macrophages to combat pancreatic cancer Myeloid cells in hepatocellular carcinoma PD-L1 and Survival in Solid Tumors: A Meta-Analysis Prevention of hepatocellular carcinoma: potential targets, experimental models, and clinical challenges Molecular classification and novel targets in hepatocellular carcinoma: recent advancements Coordinated regulation of myeloid cells by tumours Inhibition of T-cell responses by intratumoral hepatic stellate cells contribute to migration and invasion of hepatocellular carcinoma Macrophage diversity enhances tumor progression and metastasis Tumor-targeted and immune-targeted monoclonal antibodies: Going from passive to active immunotherapy.Increase of Soluble Programmed Cell Death Ligand 1 in Patients with Chronic Hepatitis C.Bu Fei Decoction attenuates the tumor associated macrophage stimulated proliferation, migration, invasion and immunosuppression of non-small cell lung cancer, partially via IL-10 and PD-L1 regulation.Exosomes from Melatonin Treated Hepatocellularcarcinoma Cells Alter the Immunosupression Status through STAT3 Pathway in Macrophages.Advances in the pathophysiology and treatment of relapsed/refractory Hodgkin's lymphoma with an emphasis on targeted therapies and transplantation strategies Transition of tumor-associated macrophages from MHC class II(hi) to MHC class II(low) mediates tumor progression in mice.Upregulation of circulating PD-L1/PD-1 is associated with poor post-cryoablation prognosis in patients with HBV-related hepatocellular carcinoma.Impact of tumour associated macrophages in pancreatic cancer.Biochemical signaling of PD-1 on T cells and its functional implications Tumor associated macrophages and neutrophils in tumor progression.B7-H1-expressing antigen-presenting cells mediate polarization of protumorigenic Th22 subsets.CXCL17 expression predicts poor prognosis and correlates with adverse immune infiltration in hepatocellular carcinoma.

P2860

Q26738293-A97F9B99-8989-4D25-B536-C66F4BAC9570 Q26738536-C1146ED2-8D0E-44CA-87F4-D583154A9513 Q26765459-456AC6D3-F31B-43BD-A4EC-14E507CF8711 Q26773072-BBDE73E5-91BE-483C-8F79-8FD37637D93B Q26773786-649FAB11-5CDB-4081-8CD2-9CEB3AB7B076 Q26778025-D66CC901-B759-45F5-8152-DBF8E727EF3A Q26779184-194AD815-0DF2-4DE6-BEA9-16039C9EBF4D Q26795411-0F1380EE-A912-403E-A3E5-73010CD56057 Q26798402-399699CC-4177-4AB4-A883-BC45B1FE1B12 Q26830170-29BB8D34-AFCE-4421-9C0D-884E0B8F6094 Q26851211-47C5AAE5-5B50-4194-857B-031A1DA09F18 Q26863283-D72C7574-290A-495E-81BA-2DC12B706240 Q26991724-6F76A521-D56C-4945-871E-F045DA211086 Q27003907-12AE6AF0-ECAA-4D6E-8B09-AB22341A2F40 Q27022816-84ABE9D8-4084-4BB9-998C-279F66EED948 Q27860852-B72A921E-BF89-4AD8-AE4B-B8D25C017CE1 Q28066941-8ECBAD6D-F8BE-4F82-9F04-5D32EA13F119 Q28072012-BAB9A3E0-44A1-4B72-BD40-8997FB9806A5 Q28073631-200D97A4-05A1-46C7-B764-F5087E52E77A Q28075712-C2A3C6ED-16EA-4B99-B599-3B956441EBDB Q28076103-39208257-DFF2-44D2-8A08-162F2D6F7DC2 Q28081161-431A2A76-47BB-4BB9-8E44-F150BD4A6325 Q28084090-9B927D1A-1982-46BE-98ED-CF55F52AC8F1 Q28272678-BF652189-5DA5-4D24-8B57-A525B11CF72A Q28383646-1A97599B-A5CE-4483-82A0-C460DBA72A26 Q28395157-7845C61F-D698-441C-BBB3-C68A7822AA5F Q28567794-66805682-E7FE-4CFC-BBA1-A9D05A856D8E Q29615847-F66789F8-68ED-4488-8650-C5754B1EEBBF Q30916013-07F2D45A-8FA8-424E-B746-96142A444773 Q33717146-24A3FC80-46B7-49EA-AF58-2CD9FF90E2A6 Q33788049-9DE3D0A5-099B-480B-BEE0-9D6CDD05EE23 Q33837257-3359CE97-F78C-4C8C-9B75-E69D0276F87B Q33886267-A77EA8D6-F79B-4ADE-918D-8D17EC3FDF9D Q33980750-71313ED4-EF37-44FE-BFDA-D95376BAD631 Q34017748-F8D53675-E005-44A8-8D7B-1ED525D854DC Q34049388-EF53717F-7BE4-4924-B85C-57893549BF0A Q34116796-C1C5175D-D22B-4234-A6CD-3783D4D07B2D Q34306107-D916AA99-5BA7-4CED-827C-BF57B8A1B8E1 Q34311714-A334C71E-15DD-40ED-AD4D-8ECF0239E6DE Q34323663-2BC6AD01-BD34-4DA7-BAD0-FD76865A2102

P2860

Activated monocytes in peritumoral stroma of hepatocellular carcinoma foster immune privilege and disease progression through PD-L1.

http://www.wikidata.org/entity/Q37273173

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 18 May 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Activated monocytes in peritum ...... ase progression through PD-L1.

@en

Activated monocytes in peritum ...... ase progression through PD-L1.

@nl

type

label

Activated monocytes in peritum ...... ase progression through PD-L1.

@en

Activated monocytes in peritum ...... ase progression through PD-L1.

@nl

prefLabel

Activated monocytes in peritum ...... ase progression through PD-L1.

@en

Activated monocytes in peritum ...... ase progression through PD-L1.

@nl

P1433

Q37273173-5325D9CA-F8C9-4BE5-ADE0-832537DD0743

P1476

Q37273173-7487D433-4917-4430-AAA1-5EC23AD0EBBB

P2093

Q37273173-0CD91252-BF3E-4646-AEC9-A114A9DF9761

Q37273173-2C4655FE-ED38-4EC3-AB02-3B31F57525C6

Q37273173-760F7191-1B97-474B-981C-B75ED63B2F70

Q37273173-AD42C652-BFC7-4DAC-B228-3C602949AF0D

Q37273173-BE45DABB-B8AF-41A3-A418-F50A08BD4AD5

Q37273173-CCEE5285-CEAC-444D-A102-937FC150730A

P2860

Q37273173-013AEC03-5663-42F7-94FF-10D374C354AB

Q37273173-081B6AB3-C1FC-44D2-A142-59A022DC7B82

Q37273173-08B04AA6-4DC1-4E71-81B6-5F7E5807FED0

Q37273173-09F2C1D3-B794-4C75-980A-F06E0D36892B

Q37273173-1B27B9BB-1CB8-4A8D-9B60-F7549F5D6736

Q37273173-1DF02207-12A3-4DAF-A791-5BA0F30CEAFB

Q37273173-216150B3-BE9F-4CA1-918E-DD0208766A71

Q37273173-29A29FC2-4891-4089-876F-5CCF455A4F51

Q37273173-2B34C3A2-9518-455E-B47D-8B2D9478314C

Q37273173-34841990-C1AB-4821-96B5-A22B47A69BA8

P304

Q37273173-C9C63A01-E97F-4B13-B3EA-2DD6511A80D4

P31

Q37273173-99A90658-A1D5-4B60-BB27-FD62E32FB5DA

P356

Q37273173-FA51A28B-51FE-4CD9-BA52-85774D6EEEAA

P407

Q37273173-3CE11AE3-A61E-49E5-93DD-62BA6B7E822C

P433

Q37273173-079EC3BF-C8AC-4021-AE22-36C183E13AAB

P478

Q37273173-72D53ED0-ECCC-40BB-8BA0-21A8EA76F050

P50

Q37273173-C032E708-07DB-452B-AF6E-252445C95D65

P577

Q37273173-D8011EEE-C5D6-4784-8888-174FE5FE6867

P5875

Q37273173-8A4BF3D1-096E-4D88-A534-DCEDBA5A2E79

P698

Q37273173-952D269E-D0C1-4FA0-BE0E-5EC507F21FA3

P932

Q37273173-DC49A752-7864-4FB6-8915-D356A4BB2E78

P356

P1433

Journal of Experimental Medicine

P1476

Activated monocytes in peritum ...... ease progression through PD-L1

@en

P2093

Changyou Wu

http://www.w3.org/2001/XMLSchema#string

Chen Peng

http://www.w3.org/2001/XMLSchema#string

Dong-Ming Kuang

http://www.w3.org/2001/XMLSchema#string

Jing Xu

http://www.w3.org/2001/XMLSchema#string

Jing-Ping Zhang

http://www.w3.org/2001/XMLSchema#string

Qiyi Zhao

http://www.w3.org/2001/XMLSchema#string

P2860

B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion

Inflammation and cancer

Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation

B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma

PD-1 and its ligands in tolerance and immunity

Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion

The B7 family revisited

Monocyte and macrophage heterogeneity

Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes

Distinct role of macrophages in different tumor microenvironments

P304

1327-1337

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1084/JEM.20082173

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

206

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-05-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24436085

http://www.w3.org/2001/XMLSchema#string

P698

19451266

http://www.w3.org/2001/XMLSchema#string

P932

2715058

http://www.w3.org/2001/XMLSchema#string